Oramed Pharmaceuticals Inc. (ORMP) income statement
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.57−0.12 (-3.25%)
Close on Nov 20, 2026Market cap $148.50MP/E 0.9Yield 7.00%
Oramed Pharmaceuticals Inc. financial ratios
See a number that looks wrong?